Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Amdocs (DOX) over the last 17 years, with Q4 2025 value amounting to -$72.4 million.

  • Amdocs' Cash from Financing Activities rose 6433.69% to -$72.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$637.5 million, marking a year-over-year increase of 1679.31%. This contributed to the annual value of -$768.1 million for FY2025, which is 37.56% up from last year.
  • As of Q4 2025, Amdocs' Cash from Financing Activities stood at -$72.4 million, which was up 6433.69% from -$192.7 million recorded in Q3 2025.
  • In the past 5 years, Amdocs' Cash from Financing Activities ranged from a high of -$72.4 million in Q4 2025 and a low of -$338.6 million during Q1 2021
  • For the 5-year period, Amdocs' Cash from Financing Activities averaged around -$182.2 million, with its median value being -$183.6 million (2024).
  • As far as peak fluctuations go, Amdocs' Cash from Financing Activities plummeted by 25333.77% in 2021, and later skyrocketed by 6433.69% in 2025.
  • Amdocs' Cash from Financing Activities (Quarter) stood at -$216.0 million in 2021, then soared by 38.14% to -$133.6 million in 2022, then tumbled by 55.64% to -$208.0 million in 2023, then increased by 2.35% to -$203.1 million in 2024, then skyrocketed by 64.34% to -$72.4 million in 2025.
  • Its last three reported values are -$72.4 million in Q4 2025, -$192.7 million for Q3 2025, and -$189.5 million during Q2 2025.